BioDlink International Company Limited (1875.HK)
BioDlink International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
3.25-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+31.0%
The outlook
BioDlink International Company Limited currently reads as leaning bearish based on below its 50- & 200-day averages, 37% of the way from its 52-week low to high, avg target +36% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Market cap
$2.36B
52-wk high
5.87
52-wk low
1.70
50-day avg
3.64
200-day avg
3.50
Trailing P/E
—